Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ketohexokinase (fructokinase) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Onchocerca volvulus | Get druggable targets OG5_133459 | All targets in OG5_133459 | |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133459 | All targets in OG5_133459 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_133459 | All targets in OG5_133459 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | ribokinase, putative | ketohexokinase (fructokinase) | 298 aa | 307 aa | 21.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0026 | 0.0473 | 0.2309 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.002 | 0.0261 | 0.1273 |
Brugia malayi | Pre-SET motif family protein | 0.0242 | 0.765 | 0.765 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0026 | 0.0473 | 0.2477 |
Entamoeba histolytica | Hypothetical protein T24C12.3, putative | 0.0012 | 0 | 0.5 |
Mycobacterium leprae | Probable adenosine kinase adk | 0.0012 | 0 | 0.5 |
Plasmodium vivax | SET domain protein, putative | 0.0035 | 0.0756 | 0.5 |
Onchocerca volvulus | 0.0275 | 0.8762 | 0.8762 | |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0026 | 0.0473 | 0.2477 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0991 | 0.5188 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.002 | 0.0261 | 0.1365 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0139 | 0.4218 | 0.4218 |
Entamoeba histolytica | kinase, PfkB family | 0.0012 | 0 | 0.5 |
Onchocerca volvulus | 0.0312 | 1 | 1 | |
Trichomonas vaginalis | set domain proteins, putative | 0.0275 | 0.8762 | 1 |
Mycobacterium ulcerans | fructokinase, PfkB | 0.0012 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0018 | 0.0193 | 1 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0054 | 0.1415 | 0.7409 |
Brugia malayi | MH2 domain containing protein | 0.0139 | 0.4218 | 0.4218 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0054 | 0.1415 | 0.7409 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0035 | 0.0756 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1415 | 0.1415 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0.0193 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0991 | 0.5188 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0139 | 0.4218 | 0.4218 |
Schistosoma mansoni | zinc finger protein | 0.0018 | 0.0193 | 0.0942 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0033 | 0.0713 | 0.3734 |
Entamoeba histolytica | ribokinase, putative | 0.0012 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.0193 | 0.0942 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1251 | 0.1251 |
Echinococcus granulosus | zinc finger protein | 0.0023 | 0.0358 | 0.1876 |
Trypanosoma brucei | ISWI complex protein | 0.0018 | 0.0193 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0087 | 0.2502 | 0.2502 |
Onchocerca volvulus | 0.0035 | 0.0756 | 0.0756 | |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0054 | 0.1415 | 0.6909 |
Mycobacterium tuberculosis | 6-phosphofructokinase PfkB (phosphohexokinase) (phosphofructokinase) | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.2336 | 0.2336 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.002 | 0.0261 | 0.1365 |
Brugia malayi | Bromodomain containing protein | 0.0044 | 0.1082 | 0.1082 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.002 | 0.0261 | 0.1273 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0054 | 0.1415 | 0.6909 |
Mycobacterium tuberculosis | Ribokinase RbsK | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0312 | 1 | 1 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0024 | 0.0399 | 0.0399 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0399 | 0.1949 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0.0193 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0023 | 0.0358 | 0.1749 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0035 | 0.0756 | 0.3689 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.1177 | 0.1177 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.1085 | 0.1085 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0242 | 0.765 | 0.765 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0069 | 0.191 | 1 |
Mycobacterium ulcerans | carbohydrate kinase CbhK | 0.0012 | 0 | 0.5 |
Entamoeba histolytica | fructokinase, putative | 0.0012 | 0 | 0.5 |
Mycobacterium tuberculosis | Adenosine kinase | 0.0012 | 0 | 0.5 |
Echinococcus multilocularis | zinc finger protein | 0.0023 | 0.0358 | 0.1876 |
Brugia malayi | Pre-SET motif family protein | 0.0035 | 0.0756 | 0.0756 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0069 | 0.191 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0035 | 0.0756 | 0.3957 |
Schistosoma mansoni | bromodomain containing protein | 0.0074 | 0.2049 | 1 |
Entamoeba histolytica | tagatose-6-phosphate kinase, putative | 0.0012 | 0 | 0.5 |
Brugia malayi | PHD-finger family protein | 0.0029 | 0.0565 | 0.0565 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0035 | 0.0756 | 0.3689 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.0284 | 0.0284 |
Giardia lamblia | Ribokinase | 0.0012 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 15 nM | Inhibition of recombinant human hepatic KHKC | ChEMBL. | 22795331 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.